April 17, 2025 01:15 PM EDT
Pharma
FDA+

GSK kicks off Blenrep re­launch plans with clear­ance from UK reg­u­la­tors

Nicole DeFeudis

Editor

The UK on Thurs­day au­tho­rized GSK’s Blenrep to treat cer­tain mul­ti­ple myelo­ma pa­tients in two dif­fer­ent reg­i­mens, mark­ing the drug’s first ap­proval world­wide since it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Phar­ma's wins and loss­es in Trump's sprawl­ing ex­ec­u­tive or­der on drug prices

In a blow to its obe­si­ty pipeline, Pfiz­er drops oral drug af­ter liv­er in­jury case

Ex­clu­sive: A small biotech will bring Roche's An­gel­man drug back to life

Eli Lil­ly re­ports first Phase 3 da­ta for oral GLP-1, post­ing a win in di­a­betes

What's Pfiz­er's next move af­ter shelv­ing its oral obe­si­ty drug danuglipron?

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times